Synopsis of recent research by authors named "Yu Mi Kang"
- Yu Mi Kang's recent research primarily focuses on the clinical implications and real-world effectiveness of diabetes treatments, particularly examining sodium-glucose cotransporter-2 inhibitors (SGLT2i) and their impacts on cardiovascular outcomes, healthcare resource utilization, and cost in diabetic populations.
- Kang's work also explores the relationships between comorbidities, exacerbations in chronic obstructive pulmonary disease (COPD), and metabolic health status, emphasizing the importance of comorbidity management in chronic conditions.
- Additionally, the research includes functional studies on plant-specific transcription factors in crops, aiming to enhance understanding of plant development and stress responses, signaling a diverse interest in both clinical and agricultural applications.
